(19)

(11)

EP 4 288 529 A2

(12)

(88) Date of publication A3: 29.09.2022 (43) Date of publication: 13.12.2023 Bulletin 2023/50 (21) Application number: 22710773.7 (22) Date of filing: 02.02.2022

(51) International Patent Classification (IPC):  C12N 9/10(2006.01) C12N 15/62(2006.01) C07K 14/705(2006.01) C12N 15/52(2006.01) A61P 35/00(2006.01) C07K 14/725(2006.01) (52) Cooperative Patent Classification (CPC): C12N 9/104; C12Y 203/02; C07K 2319/00; C12N 15/62; C07K 2319/81; A61P 35/00; C07K 14/705; C07K 14/7051; C07K 14/70521; C07K 2319/01 (86) International application number: PCT/US2022/014998 (87) International publication number: WO 2022/169913 (11.08.2022 Gazette 2022/32)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 02.02.2021 US 202163144895 P 26.09.2021 US 202163248516 P (71) Applicant: Outpace Bio, Inc. Seattle, WA 98109 (US)	(72) Inventors: MOFFETT, Howell Seattle, Washington 98102 (US) NGUYEN, Duy San Francisco, California 94080 (US) LANGAN, Robert Seattle, Washington 98122 (US) BOYKEN, Scott Seattle, Washington 98125 (US) LAJOIE, Marc Seattle, Washington 98125 (US) FOIGHT, Glenna Houston, Texas 77004 (US) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)